Compounds > cgs 10746b
Page last updated: 2024-08-23

cgs 10746b and apomorphine

cgs 10746b has been researched along with apomorphine in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boja, JW; Schechter, MD1
Altar, CA; Kim, HS; Wood, PL1

Other Studies

2 other study(ies) available for cgs 10746b and apomorphine

ArticleYear
CGS 10746B is able to attenuate the effects of amphetamine: further evidence for dopaminergic mediation.
    Pharmacology, biochemistry, and behavior, 1988, Volume: 30, Issue:4

    Topics: Alkaloids; Animals; Antipsychotic Agents; Apomorphine; Cocaine; Conditioning, Operant; Dextroamphetamine; Discrimination, Psychological; Dopamine; Dose-Response Relationship, Drug; Male; Rats; Thiazepines

1988
Presynaptic inhibition of nigrostriatal dopamine release in the mouse: lack of cross tolerance between apomorphine, GBL and CGS 10746B.
    Life sciences, 1988, Volume: 42, Issue:16

    Topics: 3,4-Dihydroxyphenylacetic Acid; 4-Butyrolactone; Animals; Apomorphine; Corpus Striatum; Dopamine; Drug Tolerance; Efferent Pathways; Furans; Male; Mice; Substantia Nigra; Thiazepines

1988